Stem Cell Therapy Market Size, Share, Growth Analysis, By Type, By Therapeutic Application, By Cell source, By Region

Description

Global stem cell therapy market size was valued at USD 11 billion in 2022 and is poised to grow from USD 12.23 billion in 2023 to USD 28.60 billion by 2031, at a CAGR of 11.2% during the forecast period (2024-2031).

The global stem cell therapy market focuses on utilizing stem cells to treat a range of diseases and conditions. Stem cells are unique because they can differentiate into various cell types and self-renew, offering potential breakthroughs in regenerative medicine. This therapy aims to repair or replace damaged tissues and organs, addressing conditions like cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, autoimmune diseases, and certain cancers where current treatments are limited. Key drivers for market growth include the rising prevalence of chronic and age-related diseases. However, the market faces challenges, such as the high costs of stem cell therapies, the need for standardized regulations, and issues related to scalability and cost-effectiveness in production. Despite these obstacles, the market holds substantial potential, with a growing pipeline of clinical trials and research studies exploring the possibilities of stem cell therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Stem Cell Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Stem Cell Therapy Market Segmental Analysis

Global stem cell therapy market is segmented on the cell source, type, therapeutic application and region. Based on cell source, the market is segmented into Adipose Tissue-derived Mesenchymal Stem Cells, Bone Marrow-derived Mesenchymal Stem Cells, Placenta/Umbilical Cord-derived Mesenchymal Stem Cells, Other. Based on type, the market is segmented into allogeneic stem cell therapy, and autologous stem cell therapy. Based on therapeutic application, the market is segmented into Musculoskeletal Disorders, Wounds & Surgeries, Regenerative Medicine, Drug Discovery and Development, Inflammatory & Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Stem Cell Therapy Market

The growing prevalence of chronic diseases, including cardiovascular disorders, neurodegenerative conditions, and orthopedic injuries, is a major factor driving the stem cell therapy market. Stem cell therapies hold the promise of regenerating damaged tissues and organs, offering innovative treatment options for conditions that currently have limited or no effective treatments. This potential for tissue repair and regeneration makes stem cell therapies an appealing solution for addressing a range of serious health issues.

Restraints in the Stem Cell Therapy Market

The substantial cost of stem cell therapies is a major obstacle to their widespread adoption. The high price is driven by factors such as extensive research and development, complex manufacturing processes, and stringent regulatory requirements. These costs can restrict access to stem cell treatments, particularly for patients in lower-income areas, thereby limiting the broader availability and implementation of these potentially transformative therapies.

Market Trends of the Stem Cell Therapy Market

Allogeneic stem cell therapies, which utilize cells from donors, are becoming increasingly popular in the market. This method provides several benefits, including standardized and readily accessible cell sources, lower manufacturing costs, and the potential for off-the-shelf treatments. As a result, many companies are now concentrating on advancing allogeneic cell therapy products, leading to a growing number of clinical trials and product development initiatives in this field.

Product Code: SQMIG35H2162

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Supply Chain Analysis
Case Study Analysis
Ecosystem of the Market
Customer & Buying Criteria Analysis
Patent Analysis
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Stem Cell Therapy Market by Cell Source

Market Overview
Adipose Tissue-derived Mesenchymal Stem Cells
Bone Marrow-derived Mesenchymal Stem Cells
Placenta/Umbilical Cord-derived Mesenchymal Stem Cells
Other

Stem Cell Therapy Market by Type

Market Overview
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy

Stem Cell Therapy Market by Therapeutic Application

Market Overview
Musculoskeletal Disorders
Wounds & Surgeries
Regenerative Medicine
Drug Discovery and Development
Inflammatory & Autoimmune Diseases
Cardiovascular Diseases
Neurological Disorders
Other

Stem Cell Therapy Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mesoblast Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celgene Corporation (a subsidiary of Bristol Myers Squibb) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TiGenix NV (a subsidiary of Takeda Pharmaceutical Company Limited) (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gamida Cell Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vericel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medipost Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osiris Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVasive, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cynata Therapeutics Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellular Dynamics International (a subsidiary of FUJIFILM Holdings Corporation) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Caladrius Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Athersys, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytori Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holostem Terapie Avanzate S.r.l. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluristem Therapeutics Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTime, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith+Nephew (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JCR Pharmaceuticals Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anterogen Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corestem, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmicell Co., Ltd (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvasive, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allosource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Holostem Terapie Avanzate Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stempeutics Research Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Regrow Biosciences Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mesoblast Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biorestorative Therapies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brainstorm Cell Limited (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viacyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kangstem Biotech Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hope Biosciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellular Biomedicine Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Personalized Stem Cells (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

Stem Cell Therapy Market Size, Share, Growth Analysis, By Type, By Therapeutic Application, By Cell source, By Region - Industry Forecast 2024-2031